Cargando…
Next-Generation Sequencing in Clinical Oncology: Next Steps Towards Clinical Validation
Compelling evidence supports the transition of next generation sequencing (NGS) technology from a research environment into clinical practice. Before NGS technologies are fully adopted in the clinic, they should be thoroughly scrutinised for their potential as powerful diagnostic and prognostic tool...
Autores principales: | Bennett, Nigel C., Farah, Camile S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276967/ https://www.ncbi.nlm.nih.gov/pubmed/25412366 http://dx.doi.org/10.3390/cancers6042296 |
Ejemplares similares
-
Clinical validation of the tempus xT next-generation targeted oncology sequencing assay
por: Beaubier, Nike, et al.
Publicado: (2019) -
Current practices and guidelines for clinical next-generation sequencing oncology testing
por: Strom, Samuel P.
Publicado: (2016) -
Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls
por: Horak, Peter, et al.
Publicado: (2016) -
Bringing the Next Generation of Immuno-Oncology Biomarkers to the Clinic
por: Cesano, Alessandra, et al.
Publicado: (2018) -
Application of next-generation sequencing in clinical oncology to advance personalized treatment of cancer
por: Guan, Yan-Fang, et al.
Publicado: (2012)